Structure of PDB 5myv Chain C |
>5myvC (length=348) Species: 9606 (Homo sapiens) [Search protein sequence] |
YHPVKIGDLFNGRYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQH YTETALDEIKLLKCVRESDPSDPNKDMVVQLIDDFKISGMNGIHVCMVFE VLGHHLLKWIIKSNYQGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKP ENILMCVDDAYVRRMAAEATLLVNPLDPRNADKIRVKIADLGNACWVHKH FTEDIQTRQYRSIEVLIGAGYSTPADIWSTACMAFELATGDYLFEPHSGE DYSRDEDHIAHIIELLGSIPRHFALSGKYSREFFNRRGELRHITKLKPWS LFDVLVEKYGWPHEDAAQFTDFLIPMLEMVPEKRASAGECLRHPWLNS |
|
PDB | 5myv Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease. |
Chain | C |
Resolution | 2.9 Å |
3D structure |
|
|
Catalytic site (original residue number in PDB) |
D225 |
Catalytic site (residue number reindexed from 1) |
D147 |
Enzyme Commision number |
2.7.11.1: non-specific serine/threonine protein kinase. |
|
Site # |
Ligand |
Ligand chain |
Binding residues on receptor (original residue number in PDB) |
Binding residues on receptor (residue number reindexed from 1) |
Binding affinity |
BS01 |
W4A |
C |
L180 G181 Y239 |
L102 G103 Y161 |
|
|
|
|